Characterization of calretinin I-II as an EF-hand, Ca2+, H +-sensing domain

Protein Science

Volumn 14, Issue 7, 2005, Pages 1879-1887

  Palczewska, Małgorzata ^a,b   Batta, Gyula ^c   Groves, Patrick ^a,d   Linse, Sara ^e   Kuźnicki, Jacek ^a,f  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^e LUND UNIVERSITY   (Sweden)

^f INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

Calbindin D28k; Calcium; Calretinin; EF hand; Ischemia; pH response

Indexed keywords

BUFFER; CALCIUM; CALRETININ; HISTIDINE; HYDROGEN; PROTON; SEPHAROSE; SULFONIC ACID DERIVATIVE;

ARTICLE; CALCIUM TRANSPORT; CHELATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELUTION; ESCHERICHIA COLI; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGANIZATION; PH; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; PROTON TRANSPORT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; BINDING SITES; CALCIUM; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; EF HAND MOTIFS; ESCHERICHIA COLI; GLUTATHIONE TRANSFERASE; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PICHIA; PROTEIN STRUCTURE, TERTIARY; PROTONS; RECOMBINANT FUSION PROTEINS; SPECTROMETRY, FLUORESCENCE;

EID: 22244462446     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.051369805     Document Type: Article

References (43)

1. Andsberg, G., Kokaia, Z., and Lindvall, O. 2001. Upregulation of p75 neurotrophin receptor after stroke in mice does not contribute to differential vulnerability of striatal neurons. Exp. Neurol. 169: 351-363.
2. Arabadzisz, D. and Freund, T.F. 1999. Changes in excitatory and inhibitory circuits of the rat hippocampus 12-14 months after complete forebrain ischemia. Neuroscience 92: 27-45.
3. 2+: Monolayer and proteolytic study. Mol. Membr. Biol. 13: 241-250.
4. Bellido, T., Huening, M., Raval-Pandya, M., Manolagas, S.C., and Christakos, S. 2000. Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity. J. Biol. Chem. 275: 26328-26332.
5. Berggård, T., Silow, M., Thulin, E., and Linse, S. 2000a. Ca(2+)- and H(+)-dependent conformational changes of calbindin D(28k). Biochemistry 39: 6864-6873.
6. Berggård, T., Thulin, E., Åkerfeldt, K.S., and Linse, S. 2000b. Fragment complementation of calbindin D28k. Protein Sci. 9: 1094-1208.
7. 2+ sensor. J. Biol. Chem. 277: 16662-16672.
8. Berggård, T., Szczepankiewicz, O., Thulin, E., and Linse, S. 2002b. Myoinositol monophosphatase is an activated target of calbindin D28k. J. Biol. Chem. 277: 41954-41959.
9. Bers, D.M. 1982. A simple method for the accurate determination of free [Ca] in Ca-EGTA solutions. Am. J. Physiol. 242: C404-C408.
10. Billing-Marczak, K. and Kuźnicki, J. 1999. Calretinin-Sensor or buffer-Function still unclear. Pol. J. Pharmacol. 51: 173-178.
11. Celio, M.R. 1996. Guidebook to the calcium-binding proteins. Sambrook & Tooze with Oxford University Press, Oxford, UK.
12. Conte, A. 2003. Physiologic pH changes modulate calcium ion dependence of brain nitric oxide synthase in Carassius auratus. Biochim. Biophys. Acta 1619: 29-38.
13. 2+-binding proteins. J. Physiol. 556: 447-461.
14. Drohat, A.C., Baldisseri, D.M., Rustandi, R.R., and Weber, D.J. 1998. Solution structure of calcium-bound rat S100B(bb) as determined by nuclear magnetic resonance spectroscopy. Biochemistry 37: 2729-2740.
15. Finn, B. and Forsen, S. 1995. The evolving model of calmodulin structure, function and activation. Structure 3: 7-11.
16. Flaherty, K.M., Zozulya, S., Stryer, L., and McKay, D.B. 1993. Three-dimensional structure of recoverin, a calcium sensor in vision. Cell 75: 709-716.
17. Fonseca, M. and Soriano, E. 1995. Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease. Brain Res. 691: 83-91.
18. Freund, T.F. and Magloczky, Z. 1993. Early degeneration of calretinin-containing neurons in the rat hippocampus after ischemia. Neuroscience 56: 581-596.
19. Gagnon, A. and Welsh, J. 1997. Modulation and phosphorylation of calbindin-D28K correlates with protein kinase C activation. Biochem. Cell Biol. 75: 33-40.
20. Gartner, W., Lang, W., Leutmetzer, F., Domanovits, H., Waldhausl, W., and Wagner, L. 2001. Cerebral expression and serum detectability of secretagogin, a recently cloned EF-hand Ca(2+)-binding protein. Cereb. Cortex 11: 1161-1169.
21. Golczak, M., Kicinska, A., Bandorowicz-Pikuła, J., Buchet, R., Szewczyk, A., and Pikuła, S. 2001. Acidic pH-induced folding of annexin VI is a prerequisite for its insertion into lipid bilayers and formation of ion channels by the protein molecules. FASEB J. 15: 1083-1085.
22. Hsu, M., Sik, A., Gallyas, F., Horvath, Z., and Buzsaki, G. 1994. Short-term and long-term changes in the postischemic hippocampus. Ann. N. Y. Acad. Sci. 743: 121-139.
23. Kawai, K., Nowak Jr., T.S., and Klatzo, I. 1995. Loss of parvalbumin immunoreactivity defines selectively vulnerable thalamic reticular nucleus neurons following cardiac arrest in the rat. Acta Neuropathol. (Berl.) 89: 262-269.
24. Kesvatera, T., Jonsson, B., Telling, A., Tougu, V., Vija, H., Thulin, E., and Linse, S. 2001. Calbindin D(9k): A protein optimized for calcium binding at neutral pH. Biochemistry 40: 15334-15340.
25. Kourie, J.I. 2001. Mechanisms of amyloid β protein-induced modification in ion transport systems: Implications for neurodegenerative diseases. Cell Mol. Neurobiol. 21: 173-213.
26. Kuźnicki, J., Winsky, L., and Jacobowitz, D.M. 1994. Ca(2+)-dependent and independent interactions of calretinin with hydrophobic resins. Biochem. Mol. Biol. Int. 33: 713-721.
27. Kuźnicki, J., Strauss, K.I., and Jacobowitz, D.M. 1995. Conformational changes and calcium binding by calretinin and its recombinant fragments containing different sets of EF hand motifs. Biochemistry 34: 15389-15394.
28. 28K and calretinin. Neuroscience 75: 523-533.
29. 28k as determined from the association of six synthetic EF-hand fragments. Protein. Sci. 6: 2385-2396.
30. Marilley, D. and Schwaller, B. 2000. Association between the calcium-binding protein calretinin and cytoskeletal components in the human colon adenocarcinoma cell line WiDr. Exp. Cell Res. 259: 12-22.
31. Matsuyama, S. and Reed, J.C. 2000. Mitochondria-dependent apoptosis and cellular pH regulation. Cell Death Differ. 7: 1155-1165.
32. Palczewska, M., Groves, P., Ambrus, A., Kaleta, A., Kövér, K.E., Batta, G., and Kuźnicki, J. 2001. Structural and biochemical characterization of neuronal calretinin domain I-II (residues 1-100); Comparison to homologous calbindin D28k domain I-II (residues 1-93). Eur. J. Biochem. 268: 6229-6237.
33. Palczewska, M., Groves, P., Batta, G., Heise, B., and Kuźnicki, J. 2003. Calretinin and calbindin D28k have different domain organizations. Protein Sci. 12: 180-184.
34. Phillips, R.G., Monje, M.L., Giuli, L.C., Meier, T.J., Yenari, M.A., Kunis, D., and Sapolsky, R.M. 2001. Gene therapy effectiveness differs for neuronal survival and behavioral performance. Gene Ther. 8: 579-585.
35. 2+-binding properties of human recombinant calretinin-22k and calretinin. J. Biol. Chem. 272: 29663-29671.
36. Shrode, L.D., Rubie, E.A., Woodgett, J.R., and Grinstein, S. 1997. Cytosolic alkalinization increases stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) activity and p38 mitogen-activated protein kinase activity by a calcium-independent mechanism. J. Biol. Chem. 272: 13653-13659.
37. Stevens, J. and Rogers, J.H. 1997. Chick calretinin: Purification, composition, and metal binding activity of native and recombinant forms. Protein Expr. Purif. 9: 171-181.
38. Tao, L., Murphy, M.E., and English, A.M. 2002. S-nitrosation of Ca(2+)-loaded and Ca(2+)-free recombinant calbindin D28k from human brain. Biochemistry 41: 6185-6192.
39. van der Goot, F.G., Gonzalez-Manas, J.M., Lakey, J.H., and Pattus, F. 1991. A "molten-globule" membrane-insertion intermediate of the pore-forming domain of colicin A. Nature 354: 408-410.
40. 2+-binding protein. J. Biol. Chem. 275: 24740-24751.
41. Yamada, K., Goto, S., Oyama, T., Yoshikawa, M., Nagahiro, S., and Ushio, Y. 1995. Striatal cells containing the Ca(2+)-binding protein calretinin (protein 10) in ischemia-induced neuronal injury. Acta Neuropathol. (Berl.) 89: 172-177.
42. Yenari, M.A., Minami, M., Sun, G.H., Meier, T.J., Kunis, D.M., McLaughlin, J.R., Ho, D.Y., Sapolsky, R.M., and Steinberg, G.K. 2001. Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke 32: 1028-1035.
43. Zhang, M., Tanakaw, T., and Ikura, M. 1995. Calcium-induced conformational transition revealed by the solution structure of apo calmodulin. Nat. Struct. Biol. 2: 758-767.